Metal-based implants are expected to be the fastest-growing segment in the interbody spine implant market, according to research from business consulting firm Prescient & Strategic Intelligence.
The spinal interbody market is expected to hit $2.5 million by 2030, according to a June 7 report. Advancements in spinal surgery technology, increased demand and adoption of minimally invasive surgery are all factors attributed to the projected 2.9 percent growth.
Metal-based implants have more than 45 percent of revenue share in the market and are growing at the highest rate. Factors include the flexibility, robustness and durability of metal-based implants.
Key players in the interbody device market include NuVasive, Medtronic, Stryker and Zimmer Biomet.